Literature DB >> 26766994

Development and validation of clinical diagnostic models for the probability of malignancy in solitary pulmonary nodules.

Jingsi Dong1, Nan Sun1, Jiagen Li1, Ziyuan Liu1, Baihua Zhang1, Zhaoli Chen1, Yibo Gao1, Fang Zhou1, Jie He1.   

Abstract

BACKGROUND: It is critical to develop a non-invasive and accurate method for differentiating between malignant and benign solitary pulmonary nodules. In large sample studies, the effectiveness of the diagnostic prediction model as a tool of assessment of the probability of malignancy is still unclear. The establishment of a diagnostic model based on large samples is needed.
METHODS: In this study, 3358 patients diagnosed with a solitary pulmonary nodule between January 2005 and March 2013, were enrolled. All patients received surgery for pulmonary nodule resection. Clinical characters, preoperative biomarker results, and computed tomography scan findings were collected. All patients were randomly separated into a training set (n = 1679) and a test set (n = 1679); we used training sets to build a diagnostic model for the malignancy probability of pulmonary nodules, and applied the test set to validate our model, as well as other published diagnostic models. RESULT: Logistic regression analysis identified 11 clinical characteristics as independent predictors of malignancy in patients with a solitary pulmonary nodule. The goodness-of-fit statistic for the model indicated that the observed proportion of malignancies did not differ from the predicted proportion (P = 0.571). The area under the curves of the receiver operator characteristic curve for our model in the training set was 0.935.
CONCLUSION: As the accuracy of the model was high, we suggest that the diagnostic model can be used as a tool to help guiding clinical decisions, when the clinician cannot make a definitive diagnosis of a solitary pulmonary nodule.

Entities:  

Keywords:  Benign; lung cancer; malignant; solitary pulmonary nodules

Year:  2014        PMID: 26766994      PMCID: PMC4704312          DOI: 10.1111/1759-7714.12077

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


  17 in total

1.  The solitary pulmonary nodule.

Authors:  Johnsey L Leef; Jeffrey S Klein
Journal:  Radiol Clin North Am       Date:  2002-01       Impact factor: 2.303

2.  The solitary pulmonary nodule.

Authors:  Neil M Ampel
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

3.  Development and validation of a clinical prediction model to estimate the probability of malignancy in solitary pulmonary nodules in Chinese people.

Authors:  Yun Li; Ke-Zhong Chen; Jun Wang
Journal:  Clin Lung Cancer       Date:  2011-09       Impact factor: 4.785

Review 4.  Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.

Authors:  M Grunnet; J B Sorensen
Journal:  Lung Cancer       Date:  2011-12-06       Impact factor: 5.705

5.  The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules.

Authors:  S J Swensen; M D Silverstein; D M Ilstrup; C D Schleck; E S Edell
Journal:  Arch Intern Med       Date:  1997-04-28

6.  Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer.

Authors:  Takeshi Hanagiri; Masakazu Sugaya; Masaru Takenaka; Sohich Oka; Tetsuro Baba; Yoshiki Shigematsu; Yoshika Nagata; Hidehiko Shimokawa; Hidetaka Uramoto; Mitsuhiro Takenoyama; Kosei Yasumoto; Fumihiro Tanaka
Journal:  Lung Cancer       Date:  2011-03-12       Impact factor: 5.705

7.  Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer.

Authors:  Kyoko Okamura; Koichi Takayama; Miiru Izumi; Taishi Harada; Kazuto Furuyama; Yoichi Nakanishi
Journal:  Lung Cancer       Date:  2013-01-23       Impact factor: 5.705

Review 8.  Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Michael K Gould; Jessica Donington; William R Lynch; Peter J Mazzone; David E Midthun; David P Naidich; Renda Soylemez Wiener
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

9.  Solitary pulmonary nodules: CT assessment.

Authors:  S S Siegelman; N F Khouri; F P Leo; E K Fishman; R M Braverman; E A Zerhouni
Journal:  Radiology       Date:  1986-08       Impact factor: 11.105

10.  Managing solitary pulmonary nodules. The choice of strategy is a "close call".

Authors:  S R Cummings; G A Lillington; R J Richard
Journal:  Am Rev Respir Dis       Date:  1986-09
View more
  7 in total

1.  Applying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions.

Authors:  Lori C Sakoda; Louise M Henderson; Tanner J Caverly; Karen J Wernli; Hormuzd A Katki
Journal:  Curr Epidemiol Rep       Date:  2017-10-24

2.  Clinical validation of a blood-based classifier for diagnostic evaluation of asymptomatic individuals with pulmonary nodules.

Authors:  Charles E Birse; Jennifer L Tomic; Harvey I Pass; William N Rom; Robert J Lagier
Journal:  Clin Proteomics       Date:  2017-07-05       Impact factor: 3.988

Review 3.  [Advances and Clinical Application of Malignant Probability Prediction Models for 
Solitary Pulmonary Nodule].

Authors:  Zhaojue Wang; Jing Zhao; Mengzhao Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-08-30

Review 4.  Lung cancer risk prediction models based on pulmonary nodules: A systematic review.

Authors:  Zheng Wu; Fei Wang; Wei Cao; Chao Qin; Xuesi Dong; Zhuoyu Yang; Yadi Zheng; Zilin Luo; Liang Zhao; Yiwen Yu; Yongjie Xu; Jiang Li; Wei Tang; Sipeng Shen; Ning Wu; Fengwei Tan; Ni Li; Jie He
Journal:  Thorac Cancer       Date:  2022-02-08       Impact factor: 3.500

Review 5.  Predictive model for the probability of malignancy in solitary pulmonary nodules: a meta-analysis.

Authors:  Gang Chen; Tian Bai; Li-Juan Wen; Yu Li
Journal:  J Cardiothorac Surg       Date:  2022-05-03       Impact factor: 1.522

6.  Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program.

Authors:  Zheng Wu; Fengwei Tan; Zhuoyu Yang; Fei Wang; Wei Cao; Chao Qin; Xuesi Dong; Yadi Zheng; Zilin Luo; Liang Zhao; Yiwen Yu; Yongjie Xu; Jiansong Ren; Jufang Shi; Hongda Chen; Jiang Li; Wei Tang; Sipeng Shen; Ning Wu; Wanqing Chen; Ni Li; Jie He
Journal:  Chin Med J (Engl)       Date:  2022-06-05       Impact factor: 6.133

7.  Solitary pulmonary nodule malignancy predictive models applicable to routine clinical practice: a systematic review.

Authors:  Marina Senent-Valero; Julián Librero; María Pastor-Valero
Journal:  Syst Rev       Date:  2021-12-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.